McAvoy David R. bought TEVA
September 5, 2025 · Form 4 insider transaction
McAvoy David R. bought 1,113 shares of Teva Pharmaceutical Industries Limited at $18.86 per share, a transaction worth $21.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,113
Price
$18.86
Total value
$21.0K
InsiderMcAvoy David R.
RoleOfficer
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateSeptember 5, 2025
Filing dateSeptember 9, 2025
Shares owned after13,027
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.